203 related articles for article (PubMed ID: 1467199)
1. Antiemetic study design: a discussion of Dr Olver's paper.
Groshen S
Br J Cancer Suppl; 1992 Dec; 19():S35-7. PubMed ID: 1467199
[No Abstract] [Full Text] [Related]
2. Measurement of success: parameters of efficacy.
de Mulder PH
Br J Cancer Suppl; 1992 Dec; 19():S68. PubMed ID: 1467205
[No Abstract] [Full Text] [Related]
3. Myths and realities of antiemetic treatment.
Martin M
Br J Cancer Suppl; 1992 Dec; 19():S46-50; discussion S50-3. PubMed ID: 1467202
[No Abstract] [Full Text] [Related]
4. The difficult trials.
Herrstedt J
Onkologie; 2009 Feb; 32(1-2):7-8. PubMed ID: 19209012
[No Abstract] [Full Text] [Related]
5. [An antiemetic guideline for patients with malignancies in Japan].
Takeuchi H; Saeki T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):976-979. PubMed ID: 20567095
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy.
Winokur SH; Baker JJ; Lokey JL; Price NA; Bowen J
J Med Assoc Ga; 1981 Apr; 70(4):263-4. PubMed ID: 7012258
[No Abstract] [Full Text] [Related]
7. Problems in antiemetic trial design and interpretation.
Krasnow SH
Oncology (Williston Park); 1989 Aug; 3(8 Suppl):5-10. PubMed ID: 2701576
[TBL] [Abstract][Full Text] [Related]
8. A new class of antiemetic agents on the horizon.
Rittenberg CN
Clin J Oncol Nurs; 2002; 6(2):103-4. PubMed ID: 11889671
[TBL] [Abstract][Full Text] [Related]
9. Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
Aapro MS
Ariz Med; 1981 Nov; 38(11):843-5. PubMed ID: 6274276
[No Abstract] [Full Text] [Related]
10. Antiemetic study design: desirable objectives, stratifications and analyses.
Olver IN
Br J Cancer Suppl; 1992 Dec; 19():S30-3; discussion S33-4. PubMed ID: 1467198
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic therapy.
Gralla RJ
Semin Oncol; 1998 Oct; 25(5):577-83. PubMed ID: 9783597
[No Abstract] [Full Text] [Related]
12. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
Egan AP; Taggart JR; Bender CM
Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
Bilgrami S; Fallon BG
Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
[TBL] [Abstract][Full Text] [Related]
14. Best practice management of CINV in oncology patients.
;
J Support Oncol; 2010; 8(2 Suppl 1):3-4. PubMed ID: 20629451
[No Abstract] [Full Text] [Related]
15. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
Jordan K; Voigt W; Schmoll HJ
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
[TBL] [Abstract][Full Text] [Related]
16. [A guideline for antimetics use for patients with malignancies].
Horie Y; Boku N
Gan To Kagaku Ryoho; 2012 Aug; 39(8):1163-8. PubMed ID: 22902437
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of malignant tumors, vomiting and nausea--what to do?].
Ell C; König HJ
Fortschr Med; 1984 Oct; 102(37):913-5. PubMed ID: 6500448
[TBL] [Abstract][Full Text] [Related]
18. Best practice management of CINV in oncology patients: II. Antiemetic guidelines and rationale for use.
Wickham R
J Support Oncol; 2010; 8(2 Suppl 1):10-5. PubMed ID: 20629453
[TBL] [Abstract][Full Text] [Related]
19. Why do we need another antiemetic? Just ask.
Kris MG
J Clin Oncol; 2003 Nov; 21(22):4077-80. PubMed ID: 14559888
[No Abstract] [Full Text] [Related]
20. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
